On February 21, 2024, after market hours, U.S. Representative Paul Gosar issued a letter to his Twitter/X feed, accusing TransMedics, among other things, of misappropriating corporate resources.
On this news, TransMedics’ stock price fell $2.18 per share, or 2.5%, to close at $84.81 per share on February 22, 2024.